Introduction
Founded by the top-notch biologist Dr. Yi Rao in 2019, Gritgen is dedicated to make "Great Science for human health" and committed to becoming a global biotech by innovative research.
-
2019
Founded in
-
3
Site
-
8600sq.m.
cGMP
-
3
Technology Platform
Mission

Vision
Value
-
Seeking Truth
-
Excellence
-
Cooperation
-
Responsibility
History
- 2023
- 2022
- 2021
- 2020
- 2019
- 2023
- 2022
- 2021
- 2020
- 2019
- 2023
- 2022
- 2021
- 2020
- 2019
-
-
January
GS1191, a gene therapeutic product for hemophilia A totally developed by Gritgen, has got IND approval and initiated Phase I trials in P.R. China.
-
-
-
January
Gritgen raised RMB 300 million for series A financing.
-
December
The cGMP commercial manufacturing facility was completed.
-
-
-
March
Patient enrollment was initiated for the investigator initiated trial (IIT) of GS1191.
-
May
The Gritgen headquarters moved to suzhou industrial park.
-
-
-
December
Gritgen raised RMB 80 million for series pre-A financing.
-
-
-
September
Gritgen Therapeutics was founded in Beijing.
-
-
Team Introduction
Founders-
Yi Rao, Ph.D.
Scientific Founder & Chairman of Scientific Advisory Board
Dr. Yi Rao was fully involved in the establishment and management of Gritgen, and provided scientific guidance for Gritgen.
Dr. Yi Rao has involved in the reform and construction of many scientific and educational institutions in China. He assisted the Chinese Academy of Sciences to establish the Institute of Neuroscience in Shanghai and participated in the establishment of the National Institute of Biological Sciences in Beijing. He founded or co-founded the Shanghai Interdisciplinary Research Center of the Chinese Academy of Sciences, the Peking University-Tsinghua University Joint Center for Life Science, the Peking University McGovern/IDG Brain Institute, and the Beijing Institute of Life Sciences. He is one of the co-sponsors of West Lake University and the former director of its Institute of Basic Medicine. He was one of the scientists that founded China's "Future Science Prize" and a co-sponsor of the "Science Discovery Award".
He is a member of the Medical Board of the Canadian Gairdner International Medical Awards.
Dr. Yi Rao got his Ph.D. degree in neuroscience from the University of California, San Francisco. He was a postdoctoral fellow in the Department of Biological Chemistry and Molecular Biology at Harvard University.
-
Jianjin Dong, M.L.
Founder & Chairman
Chairman of Gritgen
Before establishing Gritgen, Jianjin Dong engaged in the law practice in the financial market for nearly 20 years and served as the executive director of a top international financial institution and the chief lawyer of Shanghai International Energy Exchange Co., Ltd.
Jianjin Dong has extensive experience in the financial market and has provided legal advice to several financial regulators and self-regulated organizations.
-
-
Senior Executives
-
Hongyuan Wang
President
Responsible for overall corporate strategy and the Company's comprehensive operation management
Ms. Wang possesses over 19 years of extensive expertise in the fields of pharmaceutical industry.
She has worked in multinational pharmaceutical companies such as Merck, Johnson & Johnson, Servier and Bayer, holding management positions such as business head and marketing head.
She received her bachelor's degree of clinical medicine from Xiangya School of Medicine, Central South University, master of Business Administration form Guanghua School of Management, Peking University and EMBA Degree from Northwestern University (Kellogg) Business School.
-
Tenghui Yu, Ph.D.
Co-founder & Vice President, Discovery
Responsible for drug early discovery and development
Dr. Yu has deep understanding on the drug early discovery, AAV vector development and clinical translation.
She received her bachelor's degree of clinical medicine from Xiangya School of Medicine, Central South University, master of Business Administration form Guanghua School of Management, Peking University and EMBA Degree from Northwestern University (Kellogg) Business School.
-
Claire Zhang, Ph.D.
Co-founder & CTO
Responsible for the Company's CMC
Dr. Zhang has more than 30 years of experience in the field of CMC of original new drug.
Dr. Zhang has led the large-scale production of gene therapy products using the most advanced technology in the United States.
She received her PhD in molecular biology from University of Paris and her bachelor's degree in biochemistry from Nanjing University.
-
Qingliang Zhang
CFO
Responsible for the Company's financial management
Ms. Zhang has worked at investment bank for nearly ten years and possesses rich experience in investment and financing and capital market operation.
Ms. Zhang has worked at investment bank for nearly ten years and possesses rich experience in investment and financing and capital market operation.
She received her dual master's degree in electronic engineering & artificial intelligence and bachelor's degree in electronic engineering from University of Cambridge.
-
-
Founders
-
Senior Executives